trial · primary record
SGT-501
Catecholaminergic Polymorphic Ventricular Tachycardia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2031-05 |
| Primary endpoint | Number of Participants with Treatment-Emergent Adverse Event (TEAEs)s through Day 360 |
| Registry ID | NCT07148089 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:36.616Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07148089
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.